Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 12, 2005. The report details specific corporate actions regarding directors' interests in the company's Ordinary Shares and share repurchase activities conducted on May 11 and May 12, 2005.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It focuses exclusively on share transaction data:
- Share Repurchase (May 11): 750,000 shares purchased at 1,327.49 pence per share.
- Share Repurchase (May 12): 500,000 shares purchased at 1,338.11 pence per share.
- Treasury Holdings (Post-May 12): 89,073,000 shares held in treasury.
- Shares in Issue (Post-May 12): 5,853,217,051 shares (excluding treasury shares).
- Employee Trust Transfer: 25,610 Ordinary Shares transferred from the GSK Trust to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Material Changes
The filing reports a reduction in the number of shares in issue and an increase in treasury shares due to the buyback program authorized at the Annual General Meeting on May 17, 2004. Additionally, a minor adjustment occurred in the GSK Trust holdings due to the transfer of shares to employee plan participants.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Key Facts for Investor Verification
- Verify the total cost of the 1.25 million shares repurchased on May 11 and May 12, 2005.
- Confirm the current total number of shares in issue (5,853,217,051) and treasury shares (89,073,000) against subsequent filings.
- Review the remaining authority for share buybacks granted at the May 17, 2004 Annual General Meeting.
- Check for any further transactions involving the GlaxoSmithKline Employee Trust and directors' interests.